{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:53:05Z","timestamp":1767423185899},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["101-2320-B-040-006-MY3","101-OM-A-133"],"award-info":[{"award-number":["101-2320-B-040-006-MY3","101-OM-A-133"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008641","name":"Chung Shan Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008641","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.neuropharm.2012.06.018","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T09:14:32Z","timestamp":1340356472000},"page":"842-850","source":"Crossref","is-referenced-by-count":19,"title":["Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression"],"prefix":"10.1016","volume":"63","author":[{"given":"Dong-Yih","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hsien","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Shou","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Chen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.018_bib1","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1523\/JNEUROSCI.2552-05.2005","article-title":"Peptide YY(3\u201336) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis","volume":"25","author":"Acuna-Goycolea","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2008.06.032","article-title":"Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist","volume":"590","author":"Antal-Zimanyi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000125626","article-title":"Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food deprived rats","volume":"52","author":"Brady","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000054676","article-title":"Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype","volume":"74","author":"Campbell","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2011.02.019","article-title":"Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity","volume":"13","author":"Chao","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nut.2008.06.007","article-title":"Y\u00a0eat?","volume":"24","author":"Chee","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib7","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1523\/JNEUROSCI.4031-09.2010","article-title":"Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus","volume":"30","author":"Chee","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF02256608","article-title":"Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine","volume":"8","author":"Chen","year":"2001","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-6273(00)80829-6","article-title":"Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat","volume":"24","author":"Cowley","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yfrne.2006.07.002","article-title":"Physiology and gene regulation of the brain NPY Y1 receptor","volume":"27","author":"Eva","year":"2006","journal-title":"Front Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib11","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1210\/endo.141.9.7665","article-title":"The central melanocortin system can directly regulate serum insulin levels","volume":"141","author":"Fan","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/db06-0567","article-title":"Characterization of glcosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio-melanocortin networks?","volume":"56","author":"Fioramonti","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/382168a0","article-title":"A\u00a0receptor subtype involved in neuropeptide-Y-induced food intake","volume":"382","author":"Gerald","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-0115(95)00103-I","article-title":"Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding","volume":"59","author":"Heilig","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib15","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.3748\/wjg.14.6312","article-title":"Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass","volume":"14","author":"Higuchi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(97)00184-4","article-title":"Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations","volume":"756","author":"Horvath","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1037\/0735-7044.121.5.933","article-title":"Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression","volume":"121","author":"Hsieh","year":"2007","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/0269881110376692","article-title":"Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats","volume":"25","author":"Hsieh","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0167-0115(95)00110-W","article-title":"ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release","volume":"59","author":"Hulsey","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0028-3908(99)00199-9","article-title":"Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304","volume":"39","author":"Kask","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.bjp.0701969","article-title":"Evidence for involvement of neuropeptide Y\u00a0receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226","volume":"124","author":"Kask","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.physbeh.2005.10.007","article-title":"The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight","volume":"87","author":"King","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1460-9568.2003.02521.x","article-title":"Actions of neuropeptide Y and growth hormone secretagogues in the arcuate nucleus and ventromedial hypothalamic nucleus","volume":"17","author":"Kumarnsit","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2003.04.001","article-title":"Further evidence for the mediation of both subtypes of dopamine D1\/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression","volume":"147","author":"Kuo","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.regpep.2004.10.008","article-title":"Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats","volume":"127","author":"Kuo","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0024-3205(01)01401-1","article-title":"Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine","volume":"70","author":"Kuo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cbi.2009.03.013","article-title":"Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling","volume":"180","author":"Kuo","year":"2009","journal-title":"Chem-Bio. Int."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1471-4159.2010.06843.x","article-title":"The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats","volume":"114","author":"Kuo","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib29","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1089\/ars.2010.3738","article-title":"Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown","volume":"15","author":"Kuo","year":"2011","journal-title":"Antioxid. & Redox Signal."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib30","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.neuropharm.2011.11.014","article-title":"NF-kappaB knockdown can modulate amphetamine-mediated feeding response","volume":"62","author":"Kuo","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib31","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1210\/en.2008-1432","article-title":"The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus","volume":"150","author":"Lectez","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(78)90269-8","article-title":"Analysis of feeding suppression produced by perifornical hypothalamus injection of catecholamine, amphetamine and mazindol","volume":"53","author":"Leibowitz","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2009.05.018","article-title":"Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis","volume":"615","author":"Mashiko","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib34","first-page":"143","article-title":"International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-7075-4-18","article-title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour","volume":"4","author":"Millington","year":"2007","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:29:2:109","article-title":"Distribution of NPY Y5-like immunoreactivity in the rat brain","volume":"29","author":"Morin","year":"2006","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/en.138.1.196","article-title":"Neuropeptide Y induced feeding in the rat is mediated by a novel receptor","volume":"138","author":"O'Shea","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/chemse\/23.2.249","article-title":"Current status of antisense DNA methods in behavioral studies","volume":"23","author":"Ogawa","year":"1998","journal-title":"Chem. Senses"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1819.2009.01961.x","article-title":"Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence","volume":"63","author":"Okahisa","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib40","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1210\/endo.140.2.6495","article-title":"Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis","volume":"140","author":"Pu","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib42","first-page":"S73","article-title":"Exercise and the neurobiological control of food intake and energy expenditure","volume":"19","author":"Richard","year":"1995","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.6264602","article-title":"Glucoreceptors controlling feeding and blood glucose: location in the hindbrain","volume":"213","author":"Ritter","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0896-6273(04)00074-1","article-title":"Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob\/ob mice","volume":"41","author":"Roseberry","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib45","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0014-2999(94)90822-2","article-title":"The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226","volume":"271","author":"Rudolf","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0006-8993(97)00192-3","article-title":"Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes","volume":"755","author":"Sahu","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01014-5","article-title":"Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects","volume":"331","author":"Sch\u00f6bitz","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/377530a0","article-title":"The role of neuropeptide Y in the antiobesity action of the obese gene product","volume":"377","author":"Stephens","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib49","doi-asserted-by":"crossref","first-page":"RC208","DOI":"10.1523\/JNEUROSCI.22-03-j0006.2002","article-title":"Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor","volume":"22","author":"Thiele","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.numecd.2007.06.004","article-title":"Neuroendocrine control of food intake","volume":"18","author":"Valassi","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib51","first-page":"306","article-title":"Regulation of CREB expression: in\u00a0vivo evidence for a functional role in morphine action in the nucleus accumbens","volume":"276","author":"Widnell","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2010.10.110","article-title":"GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism","volume":"660","author":"Wu","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0167-0115(98)00089-5","article-title":"The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes","volume":"75-76","author":"Wyss","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib54","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1210\/endo.133.4.8404618","article-title":"Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity","volume":"133","author":"Zarjevski","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2012.06.018_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(93)90299-Z","article-title":"Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates","volume":"161","author":"Zhang","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.018_bib56","doi-asserted-by":"crossref","first-page":"R720","DOI":"10.1152\/ajpregu.00619.2009","article-title":"A\u00a0potential role for hypothalamo-medullary POMC projections in leptin-induced suppression of food intake","volume":"298","author":"Zheng","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:08:18Z","timestamp":1714090098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0028390812002766"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}